JP2009100687A - microRNA発現プロファイリングに基づく膀胱癌の検出方法 - Google Patents
microRNA発現プロファイリングに基づく膀胱癌の検出方法 Download PDFInfo
- Publication number
- JP2009100687A JP2009100687A JP2007276191A JP2007276191A JP2009100687A JP 2009100687 A JP2009100687 A JP 2009100687A JP 2007276191 A JP2007276191 A JP 2007276191A JP 2007276191 A JP2007276191 A JP 2007276191A JP 2009100687 A JP2009100687 A JP 2009100687A
- Authority
- JP
- Japan
- Prior art keywords
- mir
- mirna
- expression level
- bladder cancer
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007276191A JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | microRNA発現プロファイリングに基づく膀胱癌の検出方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007276191A JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | microRNA発現プロファイリングに基づく膀胱癌の検出方法 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012287862A Division JP5704576B2 (ja) | 2012-12-28 | 2012-12-28 | microRNA発現プロファイリングに基づく膀胱癌の検出方法 |
| JP2012287861A Division JP5704575B2 (ja) | 2012-12-28 | 2012-12-28 | microRNA発現プロファイリングに基づく膀胱癌の検出方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009100687A true JP2009100687A (ja) | 2009-05-14 |
| JP2009100687A5 JP2009100687A5 (https=) | 2011-02-24 |
Family
ID=40703169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007276191A Abandoned JP2009100687A (ja) | 2007-10-24 | 2007-10-24 | microRNA発現プロファイリングに基づく膀胱癌の検出方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2009100687A (https=) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143379A3 (en) * | 2008-05-21 | 2010-02-25 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| WO2011001906A1 (ja) | 2009-06-30 | 2011-01-06 | 富士レビオ株式会社 | 培養細胞の評価方法およびバイオマーカーのスクリーニング方法 |
| JP2011036242A (ja) * | 2009-07-16 | 2011-02-24 | Chiba Univ | miRNA発現プロファイリングに基づく尿路上皮癌の検出方法 |
| WO2012121178A1 (ja) * | 2011-03-04 | 2012-09-13 | 独立行政法人国立がん研究センター | 腫瘍血管形成阻害剤 |
| JP2013000067A (ja) * | 2011-06-17 | 2013-01-07 | Toray Ind Inc | 膀胱ガン診断用組成物及び方法 |
| CN102031254B (zh) * | 2009-09-27 | 2014-04-02 | 苏州吉玛基因股份有限公司 | 人miR-150反义核酸及其应用 |
| WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
| JPWO2013038737A1 (ja) * | 2011-09-16 | 2015-03-23 | Lsipファンド運営合同会社 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| US9006201B2 (en) | 2010-07-08 | 2015-04-14 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for diabetes |
| CN105999269A (zh) * | 2016-05-05 | 2016-10-12 | 温州医科大学 | miR-411作为膀胱癌的靶标及其应用 |
| WO2019208671A1 (ja) * | 2018-04-25 | 2019-10-31 | 東レ株式会社 | 膀胱がんの検出のためのキット、デバイス及び方法 |
| CN120118996A (zh) * | 2025-03-06 | 2025-06-10 | 三二〇一医院 | 血浆miR-9和miR-106a作为胃癌患者腹膜癌变的诊断标志物及其相关产品 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118806A2 (en) * | 2004-05-28 | 2005-12-15 | Ambion, Inc. | METHODS AND COMPOSITIONS INVOLVING MicroRNA |
| WO2006128245A1 (en) * | 2005-06-03 | 2006-12-07 | Southern Adelaide Health Service-Flinders Medical Centre | Targeting cells with altered microrna expression |
-
2007
- 2007-10-24 JP JP2007276191A patent/JP2009100687A/ja not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005118806A2 (en) * | 2004-05-28 | 2005-12-15 | Ambion, Inc. | METHODS AND COMPOSITIONS INVOLVING MicroRNA |
| JP2008500837A (ja) * | 2004-05-28 | 2008-01-17 | アンビオン インコーポレーティッド | マイクロrnaに関与する方法および組成物 |
| WO2006128245A1 (en) * | 2005-06-03 | 2006-12-07 | Southern Adelaide Health Service-Flinders Medical Centre | Targeting cells with altered microrna expression |
Non-Patent Citations (3)
| Title |
|---|
| JPN6012054374; Annual meeting. Proceedings of the American Association for Cancer Research, 48(Apr. 2007) p.423(#17 * |
| JPN6012054375; Urol. Oncol., 25[5](Sep. 2007) p.387-392 * |
| JPN6012054376; British J. Cancer, 95(2006) p.1415-1418 * |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143379A3 (en) * | 2008-05-21 | 2010-02-25 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| EP2644706A2 (en) | 2009-06-30 | 2013-10-02 | Fujirebio Inc. | Method for evaluation of cultured cells, and method for screening of biomarker |
| WO2011001906A1 (ja) | 2009-06-30 | 2011-01-06 | 富士レビオ株式会社 | 培養細胞の評価方法およびバイオマーカーのスクリーニング方法 |
| JP2011036242A (ja) * | 2009-07-16 | 2011-02-24 | Chiba Univ | miRNA発現プロファイリングに基づく尿路上皮癌の検出方法 |
| CN102031254B (zh) * | 2009-09-27 | 2014-04-02 | 苏州吉玛基因股份有限公司 | 人miR-150反义核酸及其应用 |
| US9006201B2 (en) | 2010-07-08 | 2015-04-14 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for diabetes |
| WO2012121178A1 (ja) * | 2011-03-04 | 2012-09-13 | 独立行政法人国立がん研究センター | 腫瘍血管形成阻害剤 |
| JP2013000067A (ja) * | 2011-06-17 | 2013-01-07 | Toray Ind Inc | 膀胱ガン診断用組成物及び方法 |
| JPWO2013038737A1 (ja) * | 2011-09-16 | 2015-03-23 | Lsipファンド運営合同会社 | 膀胱癌細胞の検出方法、膀胱癌細胞の検出方法に用いるプライマー及び膀胱癌マーカ |
| EP2757154A4 (en) * | 2011-09-16 | 2015-10-14 | Lsip Llc | METHOD FOR DETECTING BLOOD TUMOR CELLS, PRIMER FOR USE IN THIS METHOD FOR DETECTING BLOOD TUMOR CELLS AND BLADDER CANCER MARKERS |
| WO2015020122A1 (ja) * | 2013-08-08 | 2015-02-12 | 国立大学法人 大阪大学 | 尿路上皮癌の診断または治療剤 |
| JPWO2015020122A1 (ja) * | 2013-08-08 | 2017-03-02 | 国立大学法人大阪大学 | 尿路上皮癌の診断または治療剤 |
| CN105999269A (zh) * | 2016-05-05 | 2016-10-12 | 温州医科大学 | miR-411作为膀胱癌的靶标及其应用 |
| WO2019208671A1 (ja) * | 2018-04-25 | 2019-10-31 | 東レ株式会社 | 膀胱がんの検出のためのキット、デバイス及び方法 |
| CN120118996A (zh) * | 2025-03-06 | 2025-06-10 | 三二〇一医院 | 血浆miR-9和miR-106a作为胃癌患者腹膜癌变的诊断标志物及其相关产品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Expression profile of mammalian microRNAs in endometrioid adenocarcinoma | |
| JP2009100687A (ja) | microRNA発現プロファイリングに基づく膀胱癌の検出方法 | |
| Deb et al. | miRNAs and ovarian cancer: An overview | |
| Muralidhar et al. | Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels | |
| Porkka et al. | MicroRNA expression profiling in prostate cancer | |
| Veerla et al. | MiRNA expression in urothelial carcinomas: important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 | |
| Blenkiron et al. | MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | |
| Ramdas et al. | miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue | |
| Resnick et al. | The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform | |
| Vaz et al. | Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood | |
| White et al. | MicroRNAs and their potential for translation in prostate cancer | |
| Guancial et al. | The evolving understanding of microRNA in bladder cancer | |
| Tatarano et al. | miR-218 on the genomic loss region of chromosome 4p15. 31 functions as a tumor suppressor in bladder cancer | |
| Mezzanzanica et al. | Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications | |
| George et al. | MicroRNAs: Potential biomarkers in cancer | |
| EP2281903B1 (en) | METHOD FOR EVALUATION OF CANCER BY USING miRNA CANCER MARKER | |
| Nugent et al. | MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers | |
| CN101878314A (zh) | 用于监控结肠直肠癌的方法 | |
| WO2009012263A2 (en) | Tissue-specific micrornas and compositions and uses thereof | |
| WO2008125883A1 (en) | Cancer markers for prognosis and screening of anti-cancer agents | |
| Mehterov et al. | A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa | |
| GB2536374A (en) | Biomarkers useful for detection of types, grades and stages of human breast cancer | |
| Naeini et al. | Noncoding RNAs and cancer | |
| Salomão et al. | MicroRNA dysregulation interplay with childhood abdominal tumors | |
| MX2010012542A (es) | Metodos para evaluar el cancer colorrectal y composiciones para usar en el. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101021 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101021 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101201 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121106 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20130121 |